PANI, ALESSANDRA
 Distribuzione geografica
Continente #
EU - Europa 155.568
NA - Nord America 8.917
AS - Asia 4.333
SA - Sud America 547
AF - Africa 86
Continente sconosciuto - Info sul continente non disponibili 6
OC - Oceania 6
Totale 169.463
Nazione #
IT - Italia 150.837
US - Stati Uniti d'America 8.821
NL - Olanda 1.894
CN - Cina 1.733
SG - Singapore 1.574
UA - Ucraina 827
SE - Svezia 576
BR - Brasile 419
DE - Germania 394
VN - Vietnam 328
FI - Finlandia 315
GB - Regno Unito 297
FR - Francia 230
HK - Hong Kong 174
IN - India 124
KR - Corea 100
BD - Bangladesh 53
CA - Canada 53
AR - Argentina 50
RU - Federazione Russa 42
IQ - Iraq 33
PL - Polonia 32
JP - Giappone 27
MX - Messico 26
EC - Ecuador 24
PK - Pakistan 23
TR - Turchia 23
BE - Belgio 22
ES - Italia 22
ID - Indonesia 21
ZA - Sudafrica 20
MA - Marocco 18
CO - Colombia 17
PH - Filippine 16
SA - Arabia Saudita 16
VE - Venezuela 16
IE - Irlanda 15
MY - Malesia 11
UZ - Uzbekistan 11
MU - Mauritius 10
AT - Austria 9
CZ - Repubblica Ceca 9
LT - Lituania 9
JO - Giordania 8
KE - Kenya 7
PY - Paraguay 7
AE - Emirati Arabi Uniti 6
AU - Australia 6
DZ - Algeria 6
IL - Israele 6
LB - Libano 6
CL - Cile 5
EG - Egitto 5
EU - Europa 5
NP - Nepal 5
RO - Romania 5
AZ - Azerbaigian 4
IR - Iran 4
NG - Nigeria 4
PE - Perù 4
TN - Tunisia 4
BH - Bahrain 3
BY - Bielorussia 3
CH - Svizzera 3
DK - Danimarca 3
DO - Repubblica Dominicana 3
GR - Grecia 3
HU - Ungheria 3
LV - Lettonia 3
OM - Oman 3
PA - Panama 3
RS - Serbia 3
UY - Uruguay 3
AL - Albania 2
AM - Armenia 2
AO - Angola 2
CR - Costa Rica 2
EE - Estonia 2
ET - Etiopia 2
GE - Georgia 2
GT - Guatemala 2
HN - Honduras 2
HR - Croazia 2
JM - Giamaica 2
KG - Kirghizistan 2
KW - Kuwait 2
KZ - Kazakistan 2
LY - Libia 2
MM - Myanmar 2
NO - Norvegia 2
PT - Portogallo 2
SN - Senegal 2
SY - Repubblica araba siriana 2
TH - Thailandia 2
BG - Bulgaria 1
BO - Bolivia 1
CD - Congo 1
CI - Costa d'Avorio 1
CY - Cipro 1
GD - Grenada 1
Totale 169.452
Città #
Cagliari 148.066
Uta 2.292
Amsterdam 1.876
Singapore 852
Ashburn 736
Woodbridge 735
Fairfield 733
Chandler 706
Houston 552
Boardman 464
Jacksonville 452
Ann Arbor 434
San Jose 377
Wilmington 377
Dallas 371
Nyköping 336
Beijing 318
Seattle 287
Cambridge 247
Dearborn 207
Helsinki 182
Hefei 180
Hong Kong 152
Los Angeles 148
Nanjing 147
Lauterbourg 124
Santa Clara 121
Shanghai 118
Boston 99
Ho Chi Minh City 99
New York 93
Seoul 93
Buffalo 86
Hanoi 75
The Dalles 70
Milan 67
Shenyang 63
Nanchang 58
Guangzhou 53
São Paulo 43
Hebei 40
Jiaxing 39
Redwood City 38
San Diego 36
Verona 35
Rome 30
Jinan 29
Changsha 28
Dong Ket 28
Orem 28
Mountain View 27
Toronto 27
Falls Church 25
Tianjin 25
Warsaw 25
Brooklyn 23
Munich 22
Tokyo 21
Brussels 20
Pune 20
Redondo Beach 20
Zhengzhou 19
Council Bluffs 18
Norwalk 18
Washington 18
Frankfurt am Main 17
London 17
Chennai 16
San Francisco 16
Da Nang 15
Phoenix 14
Rio de Janeiro 14
Auburn Hills 13
Dublin 13
Haiphong 13
Manchester 13
Stockholm 13
Baghdad 12
Chicago 12
Montreal 12
Mumbai 12
Orange 12
Palermo 12
Hangzhou 11
Kunming 11
Ningbo 11
Atlanta 10
Curitiba 10
Sassari 10
Taizhou 10
Mexico City 9
Quito 9
Wuhan 9
Columbus 8
Denver 8
Johannesburg 8
New Delhi 8
Tashkent 8
Brno 7
Can Tho 7
Totale 163.548
Nome #
Mixed thiophene-phenanthroline Cu(II) complexes: synthesis, equilibria and cytotoxicity 4.827
Mixed copper-platinum complex formation could explain synergistic antiproliferative effect exhibited by binary mixtures of cisplatin and copper-1,10-phenanthroline compounds: An ESI-MS study 4.332
Mixed thiophene-phenanthroline Cu (II) complexes: synthesis, antiviral and antiproliferative activity 4.188
1H NMR brain metabonomics of scrapie exposed sheep 4.022
Novel copper(II) complexes as new promising antitumour agents. A crystal structure of [Cu(1,10-phenanthroline-5,6-dione)2(OH2)(OClO3)](ClO4) 3.958
Novel coumarins and related copper complexes with biological activity: DNA binding, molecular docking and in vitro antiproliferative activity 3.662
Lipid profiles in brains from sheep with natural scrapie 3.469
Mixed-1,10-phenanthroline-Cu(II) complexes: Synthesis, cytotoxic activity versus hematological and solid tumor cells and complex formation equilibria with glutathione 3.313
Development and validation of a general approach to predict and quantify the synergism of anti-cancer drugs using experimental design and artificial neural networks 3.242
Glucose-6-phosphate-dehydrogenase deficiency as a risk factor for pterygium 3.189
Prion seeding activities of mouse scrapie strains with divergent PrPSc protease sensitivities and amyloid plaque content using RT-QuIC and eQuIC 3.188
New Ruthenium (III) complexes with antitumor activity: design, synthesis and characterization 3.120
Platinum complexes with 1,10-phenanthroline derivatives: synthesis, kinetics and in vitro cytotoxicity. 3.088
null 3.087
Mass spectrometric discrimination of phospholipid patterns in cisplatin-resistant and -sensitive cancer cells 3.009
A Determination of Neutral Lipid and Cluster Formation for Screening Neurocognitive Impairment in Human Immunodeficiency Virus Patients 3.008
Synergistic effects of copper(II) complexes and cisplatin: an application of artificial neural networks and experimental design 2.900
Synergistic cytotoxicity of copper(II) complexes in combination with cisplatin: an application of artificial neural networks and experimental design 2.822
Cisplatin, glutathione and the third wheel: a copper-(1,10-phenthroline) complex modulates cisplatin-GSH interactions from antagonism to synergism in cancer cells resistant to cisplatin 2.658
Biochemical and molecular modifications in sheep brains during natural scrapie. 2.620
RT-QuIC assay for the detection of PrPsCJD spiked into human urine 2.594
RT-QuIC detection of PrPsCJD spiked into human urine 2.588
Drug Discovery: towards the identification and characterization of new lead compounds as anticancer and antiprion agents 2.522
Accumulation of neutral lipids in peripheral blood mononuclear cells as a distinctive trait of Alzheimer patients and asymptomatic subjects at risk of disease 2.493
Drug Discovery: towards the identification and characterization of new lead compounds for the design of new anticancer and antiprion agents 2.488
Altered cholesterol ester cycle in ex vivo skin fibroblasts from Alzheimer patients 2.443
Biochemical and molecular modifications in sheep brains during natural scrapie 2.424
Influence of hydrocortisone on cytopathic effect of Newcastle disease virus and stability to freezing of vescicular stomatitis virus 2.400
Accumulation and aberrant composition of cholesteryl esters in Scrapie-infected N2a cells and C57BL/6 mouse brains 2.302
Lipid derangement and prion misfolding in prion infected mouse neuroblastoma cells lines and in brains and skin fibroblasts from scrapie-susceptible sheep 2.277
Cholesterol homeostasis and prion misfolding: a comparative study in mouse neuroblastoma cells and in sheep brains and skin fibroblasts 2.276
Altered proteolysis in fibroblasts of alzheimer patients with predictive implications for subjects at risk of disease 2.246
Intra and intercellular distribution pf mitochondrial probes: a comparison between TMRM and JC-1 2.199
Ultrasensitive detection and quantitation of prion seeding activity by RT-QuIC and eQuIC assays 2.124
Systemic alteration of Cholesterol Homeostasis in experimental and natural scrapie 2.101
Studies on role of cholesterol in the pathogenesis of prion disorders 2.059
Ultrasensitive detection and quantitation of prion seeding activity by RT-QuIC and eQuIC assays. XII Congresso Federazione Italiana Scienze della Vita (FISV). Universita` La Sapienza Roma (Italia), 24-27 Settembre 2012. 2.055
null 1.934
Accumulation and aberrant composition of cholesteryl esters in in vitro and in vivo models of prion-infection 1.890
null 1.848
Accumulation and aberrant composition of cholesteryl esters in in vitro and in vivo models of prion-infection 1.816
Ultrasensitive detection of prion seeding activity by RT-QuIC and eQuIC assays for early diagnosis of prion diseases 1.714
Cholesterol Metabolism in Brain and Skin Fibroblasts from Sarda Breed Sheep With Scrapie-resistant and Scrapie-susceptible Genotypes 1.674
null 1.664
ACAT1, Cav-1, and PrP expression in brains and skin fibroblasts from Sarda breed sheep with scrapie-resistant and scrapie-susceptible genotype 1.228
Structure-based design, parallel synthesis, structure-activity relationship, and molecular modeling studies of thiocarbamates, new potent non-nucleoside HIV-1 reverse transcriptase inhibitor isosteres of phenethylthiazolylthiourea derivatives 1.219
Potent and selective inhibitors of human immunodeficiency virus protease structurally related to L-694,746. 1.211
1 ß ribofuranosyl pyrazolo derivati e relativo processo di produzione e impiego farmacologico 1.157
Neurodegenerative diseases and protein misfolding: novel targets and new inhibitors 1.157
null 1.142
null 1.133
Synthesis and biological evaluation of 5H-indolo [3,2-b][1,5]benzothiazepine derivatives, designed as conformationally constrained analogues of the human immunodeficiency virus type 1 reverse transcriptase inhibitor L-737,126. 1.082
MDR1 cholesterol esterification and cell growth. A comparative study in normal and multidrug resistant KB cell lines 994
Phthalein derivatives as a new tool for selectivity in thymidylate synthase inhibition 965
Changes in cholesterol metabolism in peripheral cells of Alzheimer disease patients and their relatives 965
Possibile nuovo biomarker diagnostico di malattia di Alzheimer: gli esteri del colesterolo 937
Derivatives of the new ring system indolo (1,2-c) benzo (1,2,3) triazine with potent antitumor and antimicrobial activity 850
Intra- and intercellular distribution of mitochondrial probes and changes after treatment with MDR modulators 791
Synthesis, solution equilibria and cytotoxic activity of new copper(II) complexes with 1,10-phenanthroline derivatives 773
Correlation between cholesterol esterification MDR1 gene expression and rate of cell proliferation in CEM and MOLT4 cell lines 758
Cholesterol metabolism in brain and skin fibroblasts from Sarda breed sheep with scrapie resistant or susceptible genotype 732
Protein misfolding diseases: novel targets and new inhibitors 698
Synthesis, structural characterisation, complex formation constants and in vitro cytotoxicity of some copper(II) complexes 653
Pharmacologic cholesterol homeostasis affects prion generation in a synergistic manner 638
Synthesis and antiproliferative acticity of basic thioanalogues of merbarone 627
In vitro synergistic anti-prion effect of cholesterol ester modulators in combination with chlorpromazine and quinacrine 610
Nuovi composti di sintesi atti all'impiego nella terapia delle infezioni da rhinovirus 603
Pyrazole related nucleosides. Synthesis and antiviral / antitumor activity of some substituted pyrazole and pyrazolo [4,3-d]1,2,3-triazin-4-one nucleosides 599
Antiviral activity of glycyrrhizic acid 583
Glycyrrhizic acid inhibits virus growth and inactivates virus particles 571
Role of cholesterol synthesis and esterification in the growth of CEM and MOLT4 lymphoblastic cells 560
Anti-prion activity of cholesterol esterification modulators: a comparative study in ex vivo sheep fibroblasts and lymphocytes and in mouse neuroblastoma cell lines 527
Translational control in L-cells infected by Vesicular Stomatitis Virus or Mengovirus 517
Cholesterol homeostasis: a key to prevent or slow down neurodegeneration 517
Pyrazole-related nucleosides. Design, synthesis and antiproliferative activity of methyl 4-iodo-1--D -ribofuranosyl-pyrazole-3-carboxylate (IPCAR) and derivatives, against human leukemia, lymphoma and solid tumor cell lines in vitro 511
Prpspettive in tema di antivirali 507
Inactivation by freezing of vesicular stomatitis virus treated with hydrocortisone 498
On the inhibitory effect of 2-amino-4,6-pyrimidines. 491
Oligodeossinucleotidi nativi selettivamente attivi in vitro contro il virus dell'immunodeficienza umana di tipo 1: ruolo del G-quartet. 487
Variation in resistance of cells from inbred strains of mice to herpes simplex virus type 1 452
Synthesis, biological evaluation and binding mode of novel 1-[2-(diarylmethoxy)ethyl]-2-methyl-5-nitro imidazoles targeted at the HIV-1 reverse transcriptase 451
Synthesis of new disoxaril analogues with potent and selective anti-HRV-14 activity 451
Characterization and role in morphogenesis of a new subviral particle (55S) isolated from polio infected cells 437
Changes in cholesterol metabolism-related gene expression in peripheral blood mononuclear cells from Alzheimer patients 431
A Kinase able to phosphorylate exogenous protein synthesis initiation factor eIF 2a is present in lysates of mengovirus infected L cells 430
Accumulation of cholesterol esters in ex vivo lymphocytes from scrapie-susceptible sheep and in scrapie-infected mouse neuroblastoma cell lines 429
Poliovirus morphogenesis. I. Identification of 80S dissociable particles and evidence for the artefactual production of procapsids 421
Prophylactic and/or therapeutic treatment of proliferative and conformational diseases 414
On the antiviral action of glycyrrhized acid. II. Non involvement of cell membrane transport of ions and metabolites in the antiviral effect 411
HIV-1 integrase inhibitors that block HIV-1 replication in infected cells: planning synthetic derivatives from natural products 409
Neutral Lipid Determination in Peripheral Blood Mononuclear Cells: A Useful Tool for Diagnostic and Therapeutic Interventions in Dementia 398
Perspectives in antiviral chemotherapy 398
CELL GROWTH AND CHOLESTEROL ESTERS 389
Antiherpes activity of 5 (2 bromoethyl)2' deoxyuridine 379
Models for viral resistance or dependence 378
Design, Synthesis, SAR, and Molecular Modeling Studies of Acylthiocarbamates: A Novel Series of Potent Non-nucleoside HIV-1 Reverse Transcriptase Inhibitors Structurally Related to Phenethylthiazolylthiourea Derivatives 376
null 374
On the inhibitory effect of 2 amino 4,6 dichloropyrimidine on growth of vaccinia virus 363
Pyocianine-induced DNA breakage and repair 362
null 362
Totale 155.639
Categoria #
all - tutte 216.022
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 216.022


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20214.649 0 0 0 0 0 0 0 0 0 2.031 1.593 1.025
2021/20228.256 794 899 465 592 895 617 578 349 473 779 843 972
2022/202310.222 949 1.074 1.166 912 978 1.206 433 817 733 637 823 494
2023/202411.274 573 498 530 827 1.073 1.557 1.708 818 565 833 1.250 1.042
2024/202517.322 2.468 5.066 2.680 1.885 1.278 1.269 1.498 150 283 161 242 342
2025/20267.788 423 441 847 624 583 511 1.157 340 2.337 525 0 0
Totale 169.612